# Carisma Therapeutics to Participate in Oppenheimer 35th Annual Healthcare Life Sciences Conference
Canonical URL: https://biopharmsignal.com/news/CARM/carisma-therapeutics-to-participate-in-oppenheimer-35th-annual-healthcare-life-sciences-conference
Ticker: CARM
Company: Carisma Therapeutics, Inc.
Source: Carisma Therapeutics, Inc.
Published: 2025-02-05 12:30 EST
Original Source URL: https://ir.carismatx.com
## Summary

PHILADELPHIA , Feb. 5, 2025 /PRNewswire/ -- Carisma Therapeutics Inc. (Nasdaq: CARM ) ("Carisma" or the "Company"), a leader in macrophage-focused therapeutics, today announced that Steven Kelly , President and Chief Executive Officer, will participate in the Oppenheimer 35 th Annual Healthcare

## Article Body
PHILADELPHIA , Feb. 5, 2025 /PRNewswire/ -- Carisma Therapeutics Inc. (Nasdaq: CARM ) ("Carisma" or the "Company"), a leader in macrophage-focused therapeutics, today announced that Steven Kelly , President and Chief Executive Officer, will participate in the Oppenheimer 35 th Annual Healthcare
## Recent Company News
- 2025-12-05 16:16 EST — [Carisma Announces Delisting from Nasdaq and SEC Deregistration](https://biopharmsignal.com/news/CARM/carisma-announces-delisting-from-nasdaq-and-sec-deregistration) — Source: Carisma Therapeutics, Inc.
- 2025-03-31 20:30 EST — [Carisma Therapeutics Provides Corporate Updates](https://biopharmsignal.com/news/CARM/carisma-therapeutics-provides-corporate-updates) — Source: Carisma Therapeutics, Inc.
- 2025-02-19 12:30 EST — [Carisma Therapeutics to Participate in H.C. Wainwright 3rd Annual Cell Therapy Virtual Conference](https://biopharmsignal.com/news/CARM/carisma-therapeutics-to-participate-in-h-c-wainwright-3rd-annual-cell-therapy-virtual-conference) — Source: Carisma Therapeutics, Inc.
- 2025-02-05 12:30 EST — [Carisma Therapeutics to Participate in Oppenheimer 35th Annual Healthcare Life Sciences Conference](https://biopharmsignal.com/news/CARM/carisma-therapeutics-to-participate-in-oppenheimer-35th-annual-healthcare-life-sciences-conference) — Source: Carisma Therapeutics, Inc.
- 2024-12-09 13:30 EST — [Carisma Therapeutics Announces Strategic Restructuring to Re-prioritize Pipeline](https://biopharmsignal.com/news/CARM/carisma-therapeutics-announces-strategic-restructuring-to-re-prioritize-pipeline) — Source: Carisma Therapeutics, Inc.
## Related News
- 2026-07-29 13:00 EST — ENLV — [Enlivex Management to Host Webinar to Discuss Capital Strategy, Rain Protocol Treasury Strategy, and Recent Clinical Milestones](https://biopharmsignal.com/news/ENLV/enlivex-management-to-host-webinar-to-discuss-capital-strategy-rain-protocol-tre-5921a627)
- 2026-07-29 12:30 EST — PRGO — [Perrigo to Present at the Canaccord 46th Annual Growth Conference](https://biopharmsignal.com/news/PRGO/perrigo-to-present-at-the-canaccord-46th-annual-growth-conference-40431922)
- 2026-07-29 12:30 EST — LIXT — [NOMAD Announces Operational Deployment of Two Mobile Battery Systems by DSO Electric Cooperative](https://biopharmsignal.com/news/LIXT/nomad-announces-operational-deployment-of-two-mobile-battery-systems-by-dso-elec-7fc12a2c)
- 2026-07-29 12:30 EST — RNXT — [RenovoRx to Host Second Quarter 2026 Financial Results and Business Highlights Conference Call on August 12th at 4:30 p.m. ET](https://biopharmsignal.com/news/RNXT/renovorx-to-host-second-quarter-2026-financial-results-and-business-highlights-c-8bed10ec)
- 2026-07-29 12:25 EST — ICCM — [IceCure: SIO Petitions NCCN to Include Cryoablation in Breast Cancer Treatment Guidelines, Citing IceCure's FDA Clearance  of ProSense®](https://biopharmsignal.com/news/ICCM/icecure-sio-petitions-nccn-to-include-cryoablation-in-breast-cancer-treatment-gu-bec46cd3)